Pathway nabs FDA nod for updated peripheral catheter

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has granted 510(k) clearance to Pathway Medical Technologies to market the Jetstream G3 SF (Small Fixed), the updated version of its peripheral revascularization catheter for the treatment of peripheral vascular disease.

The smaller, fixed cutter and longer catheter length allow Jetstream G3 SF to treat blockages below the knee, including the greater number of patients with critical limb ischemia and diabetes in this patient population, said the Kirkland, Wash.-based company.